66 related articles for article (PubMed ID: 19835147)
1. [Preparation and detection of phosphorylated PRAS40 (Ser183) polyclonal antibody].
Wei H; Huang B; Xu C; Zheng Z; Bai Y
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1049-54. PubMed ID: 19835147
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
Nascimento EB; Snel M; Guigas B; van der Zon GC; Kriek J; Maassen JA; Jazet IM; Diamant M; Ouwens DM
Cell Signal; 2010 Jun; 22(6):961-7. PubMed ID: 20138985
[TBL] [Abstract][Full Text] [Related]
3. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
4. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
Wang L; Harris TE; Lawrence JC
J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248
[TBL] [Abstract][Full Text] [Related]
5. Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.
Huang B; Porter G
Acta Pharmacol Sin; 2005 Oct; 26(10):1253-8. PubMed ID: 16174443
[TBL] [Abstract][Full Text] [Related]
6. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway.
Havel JJ; Li Z; Cheng D; Peng J; Fu H
Oncogene; 2015 Mar; 34(12):1487-98. PubMed ID: 24704832
[TBL] [Abstract][Full Text] [Related]
7. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
[TBL] [Abstract][Full Text] [Related]
8. Role of PRAS40 in Akt and mTOR signaling in health and disease.
Wiza C; Nascimento EB; Ouwens DM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.
Rho O; Srivastava J; Cho J; DiGiovanni J
J Invest Dermatol; 2016 Oct; 136(10):2070-2079. PubMed ID: 27349859
[TBL] [Abstract][Full Text] [Related]
10. [Research progress in PRAS40].
Chen G; Zhu G; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):685-690. PubMed ID: 30110013
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of PRAS40 enhances insulin sensitivity in skeletal muscle.
Wiza C; Chadt A; Blumensatt M; Kanzleiter T; Herzfeld De Wiza D; Horrighs A; Mueller H; Nascimento EB; Schürmann A; Al-Hasani H; Ouwens DM
Arch Physiol Biochem; 2014 May; 120(2):64-72. PubMed ID: 24576065
[TBL] [Abstract][Full Text] [Related]
12. Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.
Malla R; Ashby CR; Narayanan NK; Narayanan B; Faridi JS; Tiwari AK
Biochem Biophys Res Commun; 2015 Jul; 463(3):161-6. PubMed ID: 26003731
[TBL] [Abstract][Full Text] [Related]
13. Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.
Wang H; Zhang Q; Wen Q; Zheng Y; Lazarovici P; Jiang H; Lin J; Zheng W
Cell Signal; 2012 Jan; 24(1):17-24. PubMed ID: 21906675
[TBL] [Abstract][Full Text] [Related]
14. PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.
Xiong X; Xie R; Zhang H; Gu L; Xie W; Cheng M; Jian Z; Kovacina K; Zhao H
Neurobiol Dis; 2014 Jun; 66():43-52. PubMed ID: 24583056
[TBL] [Abstract][Full Text] [Related]
15. PRAS40: target or modulator of mTORC1 signalling and insulin action?
Nascimento EB; Ouwens DM
Arch Physiol Biochem; 2009 Oct; 115(4):163-75. PubMed ID: 19480563
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury.
Yu F; Narasimhan P; Saito A; Liu J; Chan PH
J Cereb Blood Flow Metab; 2008 Jan; 28(1):44-52. PubMed ID: 17457363
[TBL] [Abstract][Full Text] [Related]
17. Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways.
Malla R; Wang Y; Chan WK; Tiwari AK; Faridi JS
Biochem Pharmacol; 2015 Jul; 96(1):65-75. PubMed ID: 25931147
[TBL] [Abstract][Full Text] [Related]
18. The binding of PRAS40 to 14-3-3 proteins is not required for activation of mTORC1 signalling by phorbol esters/ERK.
Fonseca BD; Lee VH; Proud CG
Biochem J; 2008 Apr; 411(1):141-9. PubMed ID: 18215133
[TBL] [Abstract][Full Text] [Related]
19. Proline-rich Akt substrate of 40-kDa contains a nuclear export signal.
Wiza C; Nascimento EB; Linssen MM; Carlotti F; Herzfeld de Wiza D; van der Zon GC; Maassen JA; Diamant M; Guigas B; Ouwens DM
Cell Signal; 2013 Sep; 25(9):1762-8. PubMed ID: 23712034
[TBL] [Abstract][Full Text] [Related]
20. Determination of mTORC1 Complex Structures Reveals Regulatory Mechanisms.
Cancer Discov; 2018 Feb; 8(2):OF11. PubMed ID: 29305496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
